A novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progression (Q31143676)

29 June 2017

title

A novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progression (English)

1 reference

29 June 2017

0 references

0 references

Shogo Misumi

1

1 reference

29 June 2017

Masafumi Endo

2

1 reference

29 June 2017

Ryouzaburou Mukai

3

1 reference

29 June 2017

Kuniomi Tachibana

4

1 reference

29 June 2017

Mamoru Umeda

5

1 reference

29 June 2017

Tetsuro Honda

6

1 reference

29 June 2017

Nobutoki Takamune

7

1 reference

29 June 2017

Shozo Shoji

8

1 reference

29 June 2017

language of work or name

English

0 references

publication date

27 May 2003

1 reference

Journal of Biological Chemistry

29 June 2017

published in

1 reference

29 June 2017

volume

278

1 reference

29 June 2017

issue

34

1 reference

29 June 2017

page(s)

32335-32343

1 reference

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Co-receptors for HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Chemokine receptors: keys to AIDS pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

A new classification for HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Novel strategy for anti-HIV-1 action: selective cytotoxic effect of N-myristoyltransferase inhibitor on HIV-1-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Synthetic peptides as vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Antigenically distinct conformations of CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Real‐Time Monitoring of Antigen‐antibody Recognition on a Metal Oxide Surface by an Optical Grating Coupler Sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Analysis by surface plasmon resonance of the influence of valence on the ligand binding affinity and kinetics of an anti-carbohydrate antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Crystal structure of rhodopsin: A G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Conformationally restricted thrombin inhibitors resistant to proteolytic digestion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Safe use of the CXCR4 inhibitor ALX40-4C in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Advances in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

1 Preparation of monoclonal antibodies: Strategies and procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301209200

21 January 2018

Identifiers

DOI

10.1074/JBC.M301209200

1 reference

29 June 2017

1 reference